Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP

Objective: To examine the relationship between early clinical features, pathologies, and biochemistry of the frontotemporal lobar degenerations (FTLDs), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD). Methods: The authors conducted pathologic reexamination with the most recent immunohistochemistry of all cases diagnosed with FTLD, PSP, and CBD between 1970 and 2004. The authors also reviewed the early clinical features for clinical diagnosis and application of published research criteria. Results: Of 127 cases analyzed, 57 had a pathologic diagnosis of FTLD, 49 PSP, and 21 CBD. Of these, 38 were clinically reclassified as frontal variant frontotemporal dementia (FTD), 13 as progressive non-fluent aphasia (PNFA), 21 as CBD-like, 33 as PSP-like, and 13 with frontotemporal dementia with coexisting motor neuron disease (FTD-MND). The authors were unable to classify nine cases. All cases of FTD-MND were tau-negative and had pathologic evidence of motor neuron degeneration. All cases classified as PSP-like or CBD-like had tau-positive pathology. Of the 13 cases with PNFA, PSP and CBD accounted for almost 70% of the cases, while FTD was almost equally divided between tau-positive and tau-negative diseases. Conclusion: Frontotemporal lobar degeneration, corticobasal degeneration (CBD), and progressive supranuclear palsy (PSP) have overlapping clinical features. The prediction of tau-positive pathology from a CBD or PSP-like presentation is good, while the frontotemporal dementia (FTD)-motor neuron disease syndrome almost certainly predicts motor neuron degeneration. Surprisingly, PSP and CBD accounted for most cases classified as progressive non-fluent aphasia. Frontal variant FTD is an unpredictable disease in terms of its biochemistry.

[1]  R. Petersen,et al.  Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND , 2005, Neurology.

[2]  J. Trojanowski,et al.  Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease , 2004, Neurology.

[3]  J. Olszewski,et al.  Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia , 1964 .

[4]  D. Knopman,et al.  Dementia lacking distinctive histologie features , 1990, Neurology.

[5]  A. Rajput,et al.  Progressive Supranuclear Palsy , 2001, Drugs & aging.

[6]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[7]  W. Kamphorst,et al.  Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R , 2003, Annals of neurology.

[8]  B L Miller,et al.  Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD , 2002, Neurology.

[9]  James Lowe,et al.  Establishing a Pathological Diagnosis in Degenerative Dementias , 1998, Brain pathology.

[10]  W. Noble,et al.  Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Petersen,et al.  Antemortem diagnosis of frontotemporal lobar degeneration , 2005, Annals of neurology.

[12]  Andrew Kertesz,et al.  Relationship between Frontotemporal Dementia and Corticobasal Degeneration/Progressive Supranuclear Palsy , 2004, Dementia and Geriatric Cognitive Disorders.

[13]  I. Ferrer,et al.  Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies , 2003, Acta Neuropathologica.

[14]  D. Dickson,et al.  Frontal Lobe Dementia With Novel Tauopathy: Sporadic Multiple System Tauopathy With Dementia , 2001, Journal of neuropathology and experimental neurology.

[15]  E. Richardson,et al.  Corticodentatonigral degeneration with neuronal achromasia. , 1968, Archives of neurology.

[16]  B Miller,et al.  Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. , 2001, Archives of neurology.

[17]  Irene Litvan,et al.  Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia , 2003, Annals of neurology.

[18]  L A Hansen,et al.  Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD , 2002, Neurology.

[19]  Joseph James Duffy,et al.  Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia , 2005, Neurocase.

[20]  J. Hodges,et al.  Clinicopathological correlates in frontotemporal dementia , 2004, Annals of neurology.

[21]  J. Lowe,et al.  Motor neurone disease-inclusion dementia. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[22]  I Litvan,et al.  Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.

[23]  Nick C Fox,et al.  Neurofilament inclusion body disease: a new proteinopathy? , 2003, Brain : a journal of neurology.

[24]  R. Petersen,et al.  Progressive Nonfluent Aphasia and Subsequent Aphasic Dementia Associated with Atypical Progressive Supranuclear Palsy Pathology , 2003, European Neurology.

[25]  D. Dickson,et al.  Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain Bank , 2003, Movement disorders : official journal of the Movement Disorder Society.

[26]  D. Dickson.  Pick's Disease: A Modern Approach , 1998, Brain pathology.

[27]  E. Bigio,et al.  Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration , 2004, Acta Neuropathologica.

[28]  A. Hillis,et al.  Frontotemporal degeneration, Pick's disease, Pick complex, and Ravel , 2003, Annals of neurology.

[29]  M G Spillantini,et al.  Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. , 1999, Journal of neuropathology and experimental neurology.

[30]  G. Chang.  Arm levitation in progressive supranuclear palsy. , 2000, Neurology.

[31]  R. Forbes,et al.  Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[32]  E. Tolosa,et al.  Tau phosphorylation and kinase activation in familial tauopathy linked to deln296 mutation , 2003, Neuropathology and applied neurobiology.

[33]  Niall Quinn,et al.  Accuracy of clinical diagnosis of progressive supranuclear palsy , 2004, Movement disorders : official journal of the Movement Disorder Society.

[34]  E. Cochran,et al.  Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders , 2004 .

[35]  D. Dickson,et al.  Hippocampal Sclerosis and Ubiquitin-Positive Inclusions in Dementia Lacking Distinctive Histopathology , 2004, Dementia and Geriatric Cognitive Disorders.

[36]  M. Hallett,et al.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[37]  T. Ishihara,et al.  Pick’s Disease Pathology of a Missense Mutation of S305N of Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17: Another Phenotype of S305N , 2004, Dementia and Geriatric Cognitive Disorders.

[38]  T. Tokuda,et al.  Progressive supranuclear palsy with asymmetric tau pathology presenting with unilateral limb dystonia , 2002, Acta Neuropathologica.

[39]  Bernard Laurent,et al.  Slowly progressive anarthria with late anterior opercular syndrome: a variant form of frontal cortical atrophy syndromes , 1996, Journal of the Neurological Sciences.

[40]  Y. Mitsuyama.  Presenile dementia with motor neuron disease in Japan: clinico-pathological review of 26 cases. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[41]  M. Leandri,et al.  Trigeminal neuralgia in pontine ischaemia. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[42]  C. Broeckhoven,et al.  The role of tau (MAPT) in frontotemporal dementia and related tauopathies , 2004, Human mutation.

[43]  J. Hardy,et al.  Pick's disease is associated with mutations in the tau gene , 2000, Annals of neurology.

[44]  P. Lantos,et al.  Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration , 2002, Journal of neuropathology and experimental neurology.

[45]  Jong S. Kim,et al.  Trigeminal neuralgia after pontine infarction , 1998, Neurology.

[46]  Maria Luisa Gorno-Tempini,et al.  Clinical, Cognitive and Anatomical Evolution from Nonfluent Progressive Aphasia to Corticobasal Syndrome: A Case Report , 2004, Neurocase.

[47]  S. Chapman,et al.  Autosomal dominant progressive syndrome of motor-speech loss without dementia , 1997, Neurology.

[48]  R. Petersen,et al.  Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia , 1999, Neurology.

[49]  M N Rossor,et al.  Frontotemporal lobar degeneration and ubiquitin immunohistochemistry , 2004, Neuropathology and applied neurobiology.